Healthcare Services

Bile Duct Cancer Market Growth Driven by Increasing Liver Disease Incidence

April 17, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Bile Duct Cancer Market Between 2026 And 2030?

The bile duct cancer market size has experienced significant growth in recent years. It is forecast to increase from $2.59 billion in 2025 to $2.82 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.7%. This historic expansion can be attributed to several factors, including insufficient early diagnostic methods, a rise in liver and bile duct ailments, the expansion of oncology care centers, increased utilization of chemotherapy protocols, and a growing understanding of rare cancers.

The bile duct cancer market is forecast to experience robust expansion over the next few years, with its size projected to reach $3.89 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. This anticipated growth during the forecast period is fueled by increasing investments in precision oncology research, the rising embrace of immunotherapy treatments, the broadening of advanced diagnostic screening programs, the growing application of AI-assisted cancer diagnostics, and an escalating focus on personalized cancer treatment pathways. Significant developments expected in this period encompass a greater adoption of targeted and immunotherapy treatments, a rise in the use of advanced diagnostic imaging techniques, the increasing integration of multidisciplinary cancer care models, the expansion of precision oncology approaches, and an enhanced emphasis on early detection and staging.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/bile-duct-cancer-global-market-report

Which Major Drivers Are Influencing The Expansion Of The Bile Duct Cancer Market?

The increasing occurrence of liver diseases is projected to drive the expansion of bile duct cancer moving forward. Liver diseases involve a variety of conditions that hinder the liver’s ability to operate effectively, including hepatitis, cirrhosis, fatty liver disease, and liver cancer. The growing incidence of liver diseases is primarily fueled by elements such as increased alcohol consumption, unhealthy diets, obesity, viral infections like hepatitis, and a lack of consistent physical exercise. Bile duct cancer aids in comprehending liver diseases by highlighting the crucial role of bile ducts in liver function, as their obstruction or dysfunction frequently leads to liver-related issues such as jaundice and cholestasis. For instance, in July 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, the global prevalence of chronic liver diseases, including non-alcoholic fatty liver disease (NAFLD), reached approximately 30.2%, an increase from 26% in earlier estimates, indicating a larger population at risk for bile duct cancer. Therefore, the rising prevalence of liver diseases is propelling the growth of the bile duct cancer market.

How Is The Bile Duct Cancer Market Organized By Segment Classification?

The bile duct cancer market covered in this report is segmented –

1) By Type: Extrahepatic Bile Duct Cancer (eCCA), Intrahepatic Bile Duct Cancer (iCCA)

2) By Treatment Type: Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy

3) By Stage of Disease: Localized, Regional, Distant

4) By Diagnosis Type: Imaging Tests, Biopsy, Blood Tests

5) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Cancer Research Institutes

Subsegments:

1) By Extrahepatic Bile Duct Cancer (eCCA): Perihilar Cholangiocarcinoma (Klatskin Tumor), Distal Cholangiocarcinoma

2) By Intrahepatic Bile Duct Cancer (iCCA): Mass-Forming iCCA, Periductal Infiltrating iCCA, Intraductal Growth iCCA

Which Trends Are Shaping The Bile Duct Cancer Market?

Major companies in the bile duct cancer market are focused on developing innovative solutions, such as targeted therapies, to improve treatment outcomes, reduce side effects, and offer new hope for patients with this rare and challenging cancer. Targeted therapies are designed to focus on specific genes, proteins, or molecules that aid cancer cell growth. These treatments operate by blocking the processes that enable cancer to grow, aiming to halt tumor growth, minimize side effects, and enhance treatment results. For instance, in August 2023, Taiho Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company, announced the release of FGFR Inhibitor LYTGOBI Tablets 4 mg. The tablet formulation of LYTGOBI offers a convenient oral administration option, improving patient compliance and ease of treatment. This launch introduces a new therapeutic option for patients with advanced or metastatic bile duct cancer, particularly those with FGFR2 fusion or rearrangement mutations, thereby addressing a critical unmet need in cancer care.

Who Are The Industry Participants Involved In The Bile Duct Cancer Market?

Major companies operating in the bile duct cancer market are AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Merck & Co. Inc., Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Genentech Inc., Jazz Pharmaceuticals plc, Incyte Corporation, Exelixis Inc., Hutchison China MediTech Limited, Zymeworks Inc., Mirati Therapeutics Inc., RenovoRx Inc., Spectrum Pharmaceuticals Inc., Specialised Therapeutics Pty Ltd, Taiho Pharmaceutical Co. Ltd.

Get The Full Bile Duct Cancer Market Report:

https://www.thebusinessresearchcompany.com/report/bile-duct-cancer-global-market-report

Which Region Leads The Bile Duct Cancer Market In Terms Of Market Share?

North America was the largest region in the bile duct cancer market in 2025. The regions covered in the bile duct cancer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Bile Duct Cancer Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/bile-duct-cancer-global-market-report

Browse Through More Reports Similar to the Global Bile Duct Cancer Market 2026, By The Business Research Company

Liver Metastases Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-metastases-treatment-global-market-report

Invasive Ductal Carcinoma Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/invasive-ductal-carcinoma-therapeutics-global-market-report

Primary Biliary Cholangitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/primary-biliary-cholangitis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795